Astellas Pharma reported JPY38.22 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Sep/2025 27.83 20.06 Oct/29 2025
FY2026Q1 Jun/2025 38.22 24.13 21.00 Jul/30 2025
FY2025Q4 Mar/2025 41.84 -34.05 -18.55 Apr/25 2025
FY2025Q3 Dec/2024 -54.55 18.49 10.40 Feb/04 2025
FY2025Q2 Sep/2024 20.06 18.01 -0.80 Oct/30 2024
FY2025Q1 Jun/2024 21.00 9.73 18.46 Aug/01 2024
FY2024Q4 Mar/2024 -18.55 -18.55 -25.49 Apr/25 2024
FY2024Q3 Dec/2023 10.40 10.40 26.56 Feb/05 2024
FY2024Q2 Sep/2023 -0.80 25.57 39.28 Nov/01 2023
FY2024Q1 Jun/2023 18.46 31.34 13.6 Aug/01 2023
FY2023Q4 Mar/2023 -25.49 -13.98 -4.43 Apr/27 2023
FY2023Q3 Dec/2022 26.56 39.46 32.86 Feb/06 2023


Eps Change Date
Astellas Pharma JPY 38.22 3.62 Jun/2025
Chugai Pharma JPY 59.04 0.05 Jun/2025
Daiichi Sankyo JPY 46.03 0.28 Jun/2025
Eisai JPY 51.35 47.73 Jun/2025
Kyowa Hakko Kirin JPY 19.4 7.62 Jun/2025
M3 JPY 17.44 5.75 Jun/2025
Otsuka Holdings JPY 167.55 8.98 Jun/2025
Shionogi JPY 46.26 3.2 Jun/2025
Sumitomo Dainippon JPY 28.21 22.13 Jun/2025
Takeda JPY 79.4 145.4 Jun/2025
Terumo JPY 28.36 15.88 Jun/2025